Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2014 · third_quarter · 3T
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules.S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Source: Senate LDA
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules.S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules.S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
H.R. 436 - Health Care Cost Reduction Act of 2012; S.17-Medical Device Access & Innovation Act; H.R. 523 - Protect Medical Innovation Act of 2013
H.R. 436 - Health Care Cost Reduction Act of 2012; S.17-Medical Device Access & Innovation Act; H.R. 523 - Protect Medical Innovation Act of 2013
H.R. 436 - Health Care Cost Reduction Act of 2012; S.17-Medical Device Access & Innovation Act; H.R. 523 - Protect Medical Innovation Act of 2013
H.R. 436 - Protect Medical Innovation act of 2012; S.17-Medical Device Access & Innovation Act; FDA user fees; physician-owned companies; Medicare payment policy; gainsharing; medical device excise tax (ACA).
H.R. 436 - Protect Medical Innovation Act of 2012; S.17-Medical Device Access & Innovation Act; FDA user fees; physician-owned companies; Medicare payment policy; gainsharing; medical device excise tax (ACA)
H.R. 436 - Protect Medical Innovation Act of 2012; S.17-Medical Device Access & Innovation Act; S. 727, S.3187-Food & Drug Administration Safety & Innovation Act; physician-owned companies; Medicare payment policy; medical device excise tax (ACA)
H.R. 436 - Protect Medical Innovation Act of 2012; S.17-Medical Device Access & Innovation Act; gainsharing/disclosure/payment policy related to Medicare ACOs; bundling initiatives.
H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986; Physician-owned distributorships; CMS reimbursement; Veterans' Affairs
PL 111-148 Medical device excise tax; Physician-owned distributorships (PODs); H.R. 436 Protect Medical Innovation Act; FDA 510(k) reform proposal; Medical Device User Fee and Modernization Act (MDUFMA); S.17-Medical Device Access and Innovation Act; H.R. 1700 - Medicare Patient Empowerment Act; H.R. 1249 - Leahy-Smith America Invents Act
PL 111-148 Medical device excise tax; Physician-owned distributorships (PODs); H.R. 436 Protect Medical Innovation Act; FDA 510(k) reform proposal; Medical Device User Fee and Modernization Act (MDUFMA); S.17-Medical Device Access and Innovation Act; H.R. 1700 - Medicare Patient Empowerment Act; H.R. 1249 - Leahy-Smith America Invents Act
H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986
H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986; Physician-owned distributorships; Medicare Durable Medical Equipment ruling
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOMET, INC. · Firm: BIOMET, INC.
H.R. 3590, Patient Protection and Affordable care Act, provisions related to medical device tax and Medicare; H.R. 4872, Healthcare and Education Reconsciliation Act of 2010, provisions related to medical device tax and Medicare, 510(k) reform, and Medicare payment policy related to joint replacement ; H.R. 4213, Satellite Television Extension and Localism Act of 2010, provisions related to physician reimbursement; H.R. Temporary Extension Act of 2010, provisions related to physician reimbursement; cont. next page
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules. S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules. S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
National Knee and Hip Replacement Registry Act of 2009
Client: BIOMET, INC. · Firm: BIOMET, INC.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
National Knee and Hip Replacement Registry Act of 2009
Client: BIOMET, INC. · Firm: BIOMET, INC.
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
America's Healthy Future Act:Chairman's Mark (Senate Finance Committee)(provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician dislcosure/cunshine); S.1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement)
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); S.882; (continued next page)
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); S.882; (continued next page)
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOMET, INC. · Firm: BIOMET, INC.
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
Medicare Improvements for Patients and Providers Act of 2008
Client: BIOMET, INC. · Firm: BIOMET, INC.
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; Medicare Physician Fee Schedule ruling for FY2009 - Physician payment cuts scheduled for July, 2008; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 - Provisions relating to physician payment cuts as part of Medicare Physician Fee Schedule
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules. S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules. S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Q2
General discussion of medical device industry issues; FDA regulation; and tax reform concepts (no specific legislation discussed).
Filing targets: SENATE
2013 · fourth_quarter · Q4
CMS Medicare Physician Fee Schedule Final Rule: Physician Payment for CPT codes 27130 & 27447
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Q3
CMS Medicare Physician Fee Schedule Proposed Rule 2014; Medicare ruling on DME; Medical Device Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Q2
Argentina trade policy
Filing targets: SENATE, U.S. Trade & Development Agency (USTDA)
2013 · first_quarter · Q1
H.R. 436 - Health Care Cost Reduction Act of 2012; S.17-Medical Device Access & Innovation Act; H.R. 523 - Protect Medical Innovation Act of 2013
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Q4
H.R. 436 - Protect Medical Innovation Act of 2012; S.17-Medical Device Access & Innovation Act; gainsharing/disclosure/payment policy related to Medicare ACOs; bundling initiatives.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · 3A
H.R. 436 - Protect Medical Innovation act of 2012; S.17-Medical Device Access & Innovation Act; FDA user fees; physician-owned companies; Medicare payment policy; gainsharing; medical device excise tax (ACA).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Q3
H.R. 436 - Protect Medical Innovation Act of 2012; S.17-Medical Device Access & Innovation Act; FDA user fees; physician-owned companies; Medicare payment policy; gainsharing; medical device excise tax (ACA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Q2
H.R. 436 - Protect Medical Innovation Act of 2012; S.17-Medical Device Access & Innovation Act; S. 727, S.3187-Food & Drug Administration Safety & Innovation Act; physician-owned companies; Medicare payment policy; medical device excise tax (ACA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Q1
H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986; Physician-owned distributorships; CMS reimbursement; Veterans' Affairs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Q4
H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986; Physician-owned distributorships; Medicare Durable Medical Equipment ruling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Q3
H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Q2
PL 111-148 Medical device excise tax; Physician-owned distributorships (PODs); H.R. 436 Protect Medical Innovation Act; FDA 510(k) reform proposal; Medical Device User Fee and Modernization Act (MDUFMA); S.17-Medical Device Access and Innovation Act; H.R. 1700 - Medicare Patient Empowerment Act; H.R. 1249 - Leahy-Smith America Invents Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Q1
Section 510(k) of the Food, Drug & Cosmetic Act (Premarket Notification) - potential reforms
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · 2A
Discuss Medical Device industry; financial services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Q3
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules. S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
P.L. 111-148, Patient Protection and Affordable Care Act, provisions related to accountable care organizations and gainsharing; Tax policy; FDA 510(k) reform; Medicare Payment Policy including Outpatient Prospective Payment Ruling and the Inpatient Prospective Payment ruling for FY2010.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Q2
Discuss Medical Device industry; financial services legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
H.R. 3590, Patient Protection and Affordable care Act, provisions related to medical device tax and Medicare; H.R. 4872, Healthcare and Education Reconsciliation Act of 2010, provisions related to medical device tax and Medicare, 510(k) reform, and Medicare payment policy related to joint replacement ; H.R. 4213, Satellite Television Extension and Localism Act of 2010, provisions related to physician reimbursement; H.R. Temporary Extension Act of 2010, provisions related to physician reimbursement; cont. next page
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · 1A
Development of a clinical registry of total joint replacement managed by the Center for Medicare and Medicaid Services.
Filing targets: HOUSE OF REPRESENTATIVES
2009 · second_quarter · 2A
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); (continued) S.882 Drug and Device Accountability Act of 2009 (all provisions); H.R. 1346/S. 540 Medical Device Safety Act of 2009 (provisions related to federal pre-emptionof state laws re Class III devices) H.R. 1 Recovery Act of 2009 (provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness Research Act of 2009 (all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Q4
H.R. 2813 National Hip and Knee Replacement registry Act of 2009 (all provisions); S.301 Physician Payments sunshine Act of 2009 (all provisions); S.882 Drug and device Accountability act of 2009 (all provisions); H.R. 1346/S. 540 Medical device safety Act of 2009 (all provisions related to federal pre-emption of state laws with respect to Class III devices; H.R. 1 Recovery Act of 2009 (all provisions related to comparative effectiveness research); H.R. 2502 Comparative Effectiveness research Act of 2009 9all provisions); H.R. 2813 National Hip and Knee Replacement Registry Act of 2009 (all provisions); S. 1213 Patient-Centered Outcomes Research Act of 2009 (prov. related to stakeholder involvement in setting research agenda); H.R. 3200 America's Affordable Health Choices Act of 2009 (prov. related to comparative effectiveness (stakeholder involvement), physician reimbursement, physician disclosure/sunshine, national device registry); America's Healthy Future Act; Chairman's Mark (provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician disclosure/sunshine; S. 1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement); H.R. 3962 and S. 1796 (later known as H.R. 3590) (prov. related to excise tax on medical device companies, compensation of specialist physicians, Medicare payement reform, comparative effectiveness, and physician payment disclosures.
2009 · third_quarter · Q3
America's Healthy Future Act:Chairman's Mark (Senate Finance Committee)(provisions related to device excise tax, comparative effectiveness, physician reimbursement, physician dislcosure/cunshine); S.1213 Patient-Centered Outcomes Act of 2009 (provisions related to stakeholder involvement)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Q2
Medicare Inpatient Prospective Payment System ruling for FY2009/FY2010 - (provisions related to gainsharing/shared savings programs/ACE demonstration project/physician reimbursement); and S.301 Physician Payments Sunshine Act of 2009 (all provisions); S.882; (continued next page)
S.1213 Patient-Centered Outcomes Research Act of 2009 (provisions related to stakeholder involvement in setting research agenda)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Q1
Development of a clinical registry of total joint replacement managed by the Center for Medicare and Medicaid Services.
Filing targets: HOUSE OF REPRESENTATIVES
2008 · fourth_quarter · Q4
S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules. S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;
2008 · third_quarter · Q3
S. 2221: Transparency in Medical Device Pricing Act of 2007Price Transparency; S.2029: Physician Payments Sunshine Act of 2007; H.R. 5605: Physician Payments Sunshine Act of 2008; H.R. 6381: Medical Device Safety Act of 2008 - All provisions related to federal pre-emption of state laws with respect to Class III devices; S. 3398 Medical Device Safety Act of 2008 - All provision related to federal pre-emption of state laws with respect to Class III devices; S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules
Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; Medicare Physician Fee Schedule ruling for FY2009 - Physician payment cuts scheduled for July, 2008; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 - Provisions relating to physician payment cuts as part of Medicare Physician Fee Schedule
2008 · third_quarter · RR
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).
FDA reform of Class II and Class III device clearance/approval process - the 510(k) process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare and Medicaid legislation, Current and Future Healthcare reform issues, to include, but not limited to: S.2029 - Price transperency; S.2029, HR 5605 - Physician Payment Sunshine; HR 6381 - Pre-emption Act; S.3318 - Medicare physician payment; CMS IPPS Ruling; and FDA Globalization Act (Senate and House versions).